Log In
BCIQ
Print this Print this
 

AGE-Breaker (TRC4186)

  Manage Alerts
Collapse Summary General Information
Company Torrent Pharmaceuticals Ltd.
DescriptionAdvanced glycosylation end-product (AGE) breaker compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsPrevent diabetic complications like neuropathy, nephropathy, retinopathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today